Standard aplastic anemia therapy improves patient outcomes better than newer version, study finds

Links shared publicly online about this topic.

  • 98
    total visits

Standard aplastic anemia therapy improves patient outcomes better than newer version, study finds

sciencedaily.com

A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival significantly more than did Thymoglobulin, a similar but reportedly more potent treatment.

View full resource at sciencedaily.com

Tags: Anemia, Anemia Medication, Aplastic Anemia, Drug

  • Share

Most Recently Shared on August 3, 2011 at 11:48 pm By:

MedicalNews Medical News

Standard aplastic anemia therapy improves patient outcomes better than newer version, study finds http://bit.ly/mZ0bYA

10 months ago...

Standard aplastic anemia therapy improves patient outcomes better than newer version

medicalxpress.com — “A comparison clinical study of two aplastic anemia treatments found that ATGAM, currently the only licensed aplastic anemia drug in the United States, improved blood cell counts and survival significantly more than did Thymoglobulin, a similar but reportedly more potent treatment. The research was funded ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on August 4, 2011 at 7:50 am By:

physorg_health PhysOrg Health News Health News

Standard aplastic anemia therapy improves patient outcomes better than newer version http://tw.medicalxpress.com/231646838

10 months ago...

Advertisement